This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (38)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Travel Medicine  • Diagnosis  • Malaria  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Grant Dorsey, MD; Monica Gandhi, MD; Jessica H. Oyugi, MD; Philip J. Rosenthal, MD

Arch Intern Med. 2000;160:2505-2510.

Background  Imported malaria is quite common in the United States. Increasing antimalarial drug resistance and changes in travel patterns may have important implications for the prevention, clinical presentation, and management of this disease.

Methods  Medical records were reviewed for 121 patients with microscopically confirmed malaria diagnosed at 2 university-affiliated hospitals in San Francisco, Calif, between 1988 and 1997.

Results  Among 57 travelers from the United States, only 13 (23%) had been compliant with an appropriate chemoprophylactic regimen. No patients developed falciparum malaria after consistent chemoprophylactic therapy with mefloquine hydrochloride. However, 12 (19%) of US residents with imported malaria developed Plasmodium vivax or Plasmodium ovale infections despite an appropriate chemoprophylactic regimen, generally with a late onset suggestive of relapsing disease. Clinical presentations were similar between foreign residents and American travelers and between patients with falciparum and nonfalciparum infections; 98% of patients had a history of fever. Sixteen percent of patients had received previous evaluations during which the diagnosis of malaria was not considered. In 9% of patients, there were errors in treatment. Only 1 patient developed severe malaria.

Conclusions  Our results suggest that a standard chemoprophylactic regimen is highly effective in preventing falciparum malaria, but that many American travelers do not receive it. Also, relapsing P vivax or P ovale infection despite appropriate chemoprophylactic therapy was not uncommon among our cases. The presentation of imported malaria is nonspecific, highlighting the need to consider the diagnosis in any febrile patient who has been in a malaria-endemic area. Although errors in diagnosis and treatment were quite common in our study population, patient outcomes were good once the appropriate therapy was initiated.

From the Department of Medicine, University of California, San Francisco.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Quinidine and Malaria
Helmut Albrecht, Jeffrey Lennox, Carlos del Rio, Grant Dorsey, and Philip J. Rosenthal
Arch Intern Med. 2001;161(8):1118-1119.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(16):2551-2552.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Malaria in the United States: A Systematic Review
Griffith et al.
JAMA 2007;297:2264-2277.
ABSTRACT | FULL TEXT  

Malaria-Related Deaths among U.S. Travelers, 1963-2001
Newman et al.
ANN INTERN MED 2004;141:547-555.
ABSTRACT | FULL TEXT  

Problems in the Therapy for Imported Malaria in the United States
Singh et al.
Arch Intern Med 2003;163:2027-2030.
ABSTRACT | FULL TEXT  

INFECTIOUS DISEASES IN IMMIGRANTS FROM THE PERSPECTIVE OF A TROPICAL MEDICINE REFERRAL UNIT
LOPEZ-VELEZ et al.
Am J Trop Med Hyg 2003;69:115-121.
ABSTRACT | FULL TEXT  

Illness after International Travel
Ryan et al.
NEJM 2002;347:505-516.
FULL TEXT  

Integrated Approach to Malaria Control
Shiff
Clin. Microbiol. Rev. 2002;15:278-293.
ABSTRACT | FULL TEXT  

The Diagnosis of Imported Malaria
Cunha
Arch Intern Med 2001;161:1926-1928.
FULL TEXT  

Quinidine and Malaria
Albrecht et al.
Arch Intern Med 2001;161:1118-1119.
FULL TEXT